Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Sana Siddig"'
Autor:
Marie-Lise Jobin, Sana Siddig, Zsombor Koszegi, Yann Lanoiselée, Vladimir Khayenko, Titiwat Sungkaworn, Christian Werner, Kerstin Seier, Christin Misigaiski, Giovanna Mantovani, Markus Sauer, Hans M. Maric, Davide Calebiro
Publikováno v:
Nature Communications, Vol 14, Iss 1, Pp 1-14 (2023)
GABAB receptors mediate the effects of the main inhibitory neurotransmitter in the brain. Here, authors identify the cytoskeletal protein filamin A as a key player that controls the exact location and function of GABAB receptors at the cell surface.
Externí odkaz:
https://doaj.org/article/151c7286e0224e3e936b73cfadb10add
Autor:
Joshua Jackson, Lena Wischhof, Enzo Scifo, Anna Pellizzer, Yiru Wang, Antonia Piazzesi, Debora Gentile, Sana Siddig, Miriam Stork, Chris E. Hopkins, Kristian Händler, Joachim Weis, Andreas Roos, Joachim L. Schultze, Pierluigi Nicotera, Dan Ehninger, Daniele Bano
Publikováno v:
Molecular Metabolism, Vol 61, Iss , Pp 101503- (2022)
Objective: Mitochondrial “retrograde” signaling may stimulate organelle biogenesis as a compensatory adaptation to aberrant activity of the oxidative phosphorylation (OXPHOS) system. To maintain energy-consuming processes in OXPHOS deficient cell
Externí odkaz:
https://doaj.org/article/9d8b2a62ba88416c9f9326255683b183
Autor:
Marie-Lise Jobin, Christian Werner, Sarah Aufmkolk, Davide Calebiro, Markus Sauer, Sana Siddig, Sören Doose
Publikováno v:
Science Advances
Super-resolution imaging reveals close association between mGluR4, CaV2.1, and Munc-18-1 at cerebellar active zones.
G protein–coupled receptors (GPCRs) play a fundamental role in the modulation of synaptic transmission. A pivotal example is p
G protein–coupled receptors (GPCRs) play a fundamental role in the modulation of synaptic transmission. A pivotal example is p
Despite the large number of G protein-coupled receptors (GPCRs) expressed in the central nervous system (CNS), little is known about their location, organization, and dynamics in functional nanodomains at synapses. Class C GPCRs including metabotropi
Despite the large number of G protein-coupled receptors (GPCRs) expressed in the central nervous system (CNS), little is known about their location, organization, and dynamics in functional nanodomains at synapses. Class C GPCRs including metabotropi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______713::3bc8bef0d0a08329a0c75c74369b9062
https://opus.bibliothek.uni-wuerzburg.de/frontdoor/index/index/docId/17896
https://opus.bibliothek.uni-wuerzburg.de/frontdoor/index/index/docId/17896
Autor:
Katsunori Yamaura, Tomoya Uehara, Yuki Nomura, Keisuke Gushimiyagi, Sana Siddig, Miaki Uzu, Yuko Sekine, Koichi Ueno, Yasushi Arano, Hiromi Sato, Tatsuro Kashiba, Sayumi Suzuki
Publikováno v:
European Journal of Pharmacology. 746:258-266
Intrinsic drug resistance occurs in many renal carcinomas and is associated with increased expression of multidrug resistant proteins, which inhibits intracellular drug accumulation. Multidrug resistant protein 1, also known as P-glycoprotein, is a m
Autor:
Sana Siddig, Hiromi Sato, Guligena Tuerdi, Hiroki Iwata, Eriko Suwa, Tomohiro Yano, Koichi Ueno, Saki Ichinomiya
Publikováno v:
Cancer Letters. 339:116-127
The present study is the first to demonstrate the synergetic effect of statins (atorvastatin and simvastatin) and gamma-tocotrienol (γ-T3) on human malignant mesothelioma (MM). Statin + γ-T3 combinations induced greater cell growth inhibition more
Autor:
Tomohiro Yano, Sana Siddig, Yuki Nomura, Guligena Tuerdi, Miaki Uzu, Hiromi Sato, Hiroko Okuzawa, Sayumi Suzuki, Koichi Ueno, Rina Suzuki, Yuko Sekine
Publikováno v:
Cancer Research. 73:1043-1043
Sunitinib (SU) is a multi-targeted receptor tyrosine kinase inhibitor (TKI). It is more effective for renal cell carcinoma (RCC) treatment than conventional immunotherapy, but it causes the resistance and severe side effects in some cases. As a combi
Autor:
Yasushi Arano, Hiromi Sato, Yuko Sekine, Yuki Nomura, Sana Siddig, Koichi Ueno, Tomoya Uehara, Miaki Uzu, Rina Suzuki, Sayumi Suzuki
Publikováno v:
Cancer Research. 73:983-983
Sunitinib is a multi-targeted receptor tyrosine kinase inhibitor (TKI) and currently approved for use in advanced renal cell carcinoma (RCC). It is really attractive drug for patients who cannot have surgical treatment. However, it is reported that T